J. Ahn

Kyung-Ja Cho, Jin-Hee Ahn, J. Song, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Intramedullary spinal cord metastases: a single-institution experience

Sung-Bae Kim, Jin-Hee Ahn, S. Sym, 2007, Journal of Neuro-Oncology.

A phase II trial of the pan‐HER inhibitor poziotinib, in patients with HER2‐positive metastatic breast cancer who had received at least two prior HER2‐directed regimens: results of the NOV120101‐203 trial

Sung-Bae Kim, J. Ahn, Yeon-Hee Park, 2018, International journal of cancer.

Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component

Dae-Ho Lee, Choung-Soo Kim, Y. Cho, 2013, Journal of Cancer Research and Clinical Oncology.

Oral Doxifluridine Plus Leucovorin in Metastatic Colorectal Cancer: Randomized Phase II Trial With Intravenous 5-Fluorouracil Plus Leucovorin

C. Yu, Yoon-Koo Kang, Jin-Hee Ahn, 2003, American journal of clinical oncology.

Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report.

S. Ahn, C. Yu, Yoon-Koo Kang, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study

Yeul-Hong Kim, Jeeyun Lee, H. Lim, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Treatment outcome of postoperative radiotherapy for retroperitoneal sarcoma

Sang‐wook Lee, Song-Cheol Kim, Jong Hoon Kim, 2011, Radiation oncology journal.

Abstract GS1-01: KEYNOTE-522 study of neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses

P. Fasching, L. Pusztai, C. Denkert, 2022, Cancer Research.

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)

Sung-Bae Kim, Yeon-Hee Park, S. Im, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS

Hee Jung Shin, Joo Hee Cha, Jin-Hee Ahn, 2012, NMR in biomedicine.

The Clinical Characteristics and Outcome of Breast Cancer Patients Older than 70 Years.

Sung-Bae Kim, S. Ahn, S. Ahn, 2007 .

The Recurrence Rate, Risk Factors and Recurrence Patterns after Surgery in 3700 Patients with Operable Breast Cancer

Sung-Bae Kim, S. Ahn, S. Yun, 2006 .

Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial

Sung-Bae Kim, Y. Im, S. Kang, 2014, Investigational New Drugs.

Prospective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapy

Sung-Bae Kim, S. Ahn, K. Jung, 2012, Cancer Chemotherapy and Pharmacology.

Monogenic and polygenic determinants of sarcoma risk: an international genetic study.

David M. Thomas, R. Sarin, J. Blay, 2016, The Lancet. Oncology.

Undervaluation of Radiotherapy for Gross Desmoid Tumors: The Need for Absolute Volume Assessment

E. Choi, Jin-Hee Ahn, H. Chung, 2021, In Vivo.

Active surveillance for metastatic or recurrent renal cell carcinoma

Dae-Ho Lee, Jin-Hee Ahn, Jae-Lyun Lee, 2014, Journal of Cancer Research and Clinical Oncology.

P30 Tissue microarray-based studies of patients with lymph node-negative breast carcinoma show that HER-2/neu overexpression is an important predictive marker of poor prognosis

M. Kim, S. Lee, Sung-Bae Kim, 2007 .

Comparative Efficacy of Sunitinib versus Sorafenib as First-Line Treatment for Patients with Metastatic Renal Cell Carcinoma

Dae-Ho Lee, Choung-Soo Kim, Jin-Hee Ahn, 2013, Chemotherapy.

Comparative efficacy of sunitinib versus sorafenib as the first-line treatment for patients with metastatic renal cell carcinoma.

Dae-Ho Lee, Choung-Soo Kim, Jin-Hee Ahn, 2012 .

Hand‐Foot Syndrome in Patients Treated With Capecitabine‐Containing Combination Chemotherapy

Tae Won Kim, H. Chang, Yoon-Koo Kang, 2004, Journal of clinical pharmacology.

Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide

Jin-Hee Ahn, Jeeyun Lee, S. Rha, 2013, Investigational New Drugs.

Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.

H. Lee, G. Gong, Jin-Hee Ahn, 2015, American journal of clinical pathology.

A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by [18F]fluorothymidine-positron emission tomography

Jin-Hee Ahn, Jin-Hee Ahn, S. Oh, 2013, Investigational New Drugs.

A pilot study for the early assessment of the effects of BMS-754807 plus gefitinib in an H292 tumor model by ( 18 F)fluorothymidine-

Sang-We Kim, Jin-Hee Ahn, E. J. Kim, 2013 .

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer

H. Lee, S. Y. Park, G. Gong, 2014, Breast Cancer Research and Treatment.

Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02.

Sung-Bae Kim, J. Ahn, Yeon-Hee Park, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reduction.

Dae-Ho Lee, Choung-Soo Kim, Jin-Hee Ahn, 2010, Japanese journal of clinical oncology.

The Role and Clinical Effectiveness of Multiline Chemotherapy in Advanced Desmoplastic Small Round Cell Tumor

Kyung-Ja Cho, J. Song, Young-Hoon Kim, 2021, Clinical Medicine Insights. Oncology.

Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy.

Kyung-Ja Cho, Sung-Bae Kim, Ho-Young Song, 2008, International journal of radiation oncology, biology, physics.

Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis

C. Yoo, S. Chun, T.W. Kim, 2023, ESMO open.

Expression of Lewis X is associated with poor prognosis in triple-negative breast cancer.

H. Lee, G. Gong, Jin-Hee Ahn, 2013, American journal of clinical pathology.

A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)

Sung-Bae Kim, J. Ahn, Yeon-Hee Park, 2022, Cancer research and treatment.

Response evaluation criteria in solid tumors response of the primary lesion in metastatic renal cell carcinomas treated with sunitinib: does the primary lesion have to be regarded as a target lesion?

Choung-Soo Kim, Jin-Hee Ahn, Kwonoh Park, 2013, Clinical genitourinary cancer.

Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)

Sung-Bae Kim, Yeon-Hee Park, Y. Im, 2019, British Journal of Cancer.

Postoperative Radiotherapy After Limb-sparing Surgery for Soft-tissue Sarcomas of the Distal Extremities.

Jin-Hee Ahn, H. Chung, S. Song, 2016, Anticancer research.

Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane

Sung-Bae Kim, S. Ahn, J. Park, 2004, Journal of Korean medical science.

Efficacy of assessing circulating cell-free DNA using a simple fluorescence assay in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a prospective observational study

Sung-Bae Kim, G. Gong, K. Jung, 2017, Oncotarget.

Radiation therapy with UFT and low dose weekly cisplatin for nasopharyngeal carcinoma.

Kyung-Ja Cho, Sang‐wook Lee, Sung-Bae Kim, 2005, Auris, nasus, larynx.

Expression of FOXM1 and related proteins in breast cancer molecular subtypes

Sung-Bae Kim, E. Cho, S. Ahn, 2016, International journal of experimental pathology.

High-dose chemotherapy of cyclophosphamide, thiotepa and carboplatin (CTCb) followed by autologous stem-cell transplantation as a consolidation for breast cancer patients with 10 or more positive lymph nodes: a 5-year follow-up results.

Sung-Bae Kim, Sang-We Kim, Jin-Hee Ahn, 2005, Cancer research and treatment : official journal of Korean Cancer Association.

LUX-breast 1: Randomized, phase III trial of afatinib and vinorelbine versus trastuzumab and vinorelbine in patients with HER2-overexpressing metastatic breast cancer (MBC) failing one prior trastuzumab treatment.

Chiun-Sheng Huang, Bing-he Xu, N. Harbeck, 2012 .

Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer

Sung-Bae Kim, S. Ahn, H. Lee, 2015, Tumor Biology.

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Tae Won Kim, J. H. Park, K. Jung, 2019, Journal of Cancer Education.

How cancer patients perceive clinical trials (CTs) in the era of CTs: Current perceptional status and differences between common and rare cancers

Tae Won Kim, J. H. Park, K. Jung, 2018, bioRxiv.

Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.

Soo Young Kim, Kyung-Ja Cho, Sung-Bae Kim, 2007, European journal of cancer.

Comparison of Pathologic Response Evaluation Systems after Anthracycline with/without Taxane-Based Neoadjuvant Chemotherapy among Different Subtypes of Breast Cancers

Sung-Bae Kim, S. Ahn, H. Lee, 2015, PloS one.

Clinical value of cyclooxygenase-2 expression in human breast carcinoma.

Sung-Bae Kim, S. Ahn, M. Ahn, 2004, Cancer research and treatment : official journal of Korean Cancer Association.

Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review

C. Porta, M. Neary, W. Oh, 2013, International journal of oncology.

Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting

H. Lee, G. Gong, Jin-Hee Ahn, 2014, Tumor Biology.

Usefulness of 3D-surgical guides in breast conserving surgery after neoadjuvant treatment

J. Seo, Namkug Kim, S. Ahn, 2021, Scientific Reports.

Brain metastases in breast cancer: prognostic factors and management

Sung Sook Lee, Sung-Bae Kim, S. Ahn, 2008, Breast Cancer Research and Treatment.

FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment

Sung-Bae Kim, H. Lee, G. Gong, 2018, Journal of breast cancer.

Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer

Sung-Bae Kim, S. Ahn, H. Lee, 2014, BMC Cancer.

Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG s

Sung-Bae Kim, J. Ahn, Yeon-Hee Park, 2018, European journal of cancer.

Clinical outcomes of angiosarcoma: a single institution experience

Jin-Hee Ahn, S. Seo, S. Song, 2019, Cancer communications.

Characteristics of metastatic brachial plexopathy in patients with breast cancer

Sung-Bae Kim, Y. Choi, K. Jung, 2019, Supportive Care in Cancer.

Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor‐infiltrating lymphocytes (TILs) in breast cancer

H. Lee, G. Gong, Jin-Hee Ahn, 2016, Pathology international.

Heritable defects in telomere and mitotic function selectively predispose to sarcomas

Melissa J. Green, Emma M. Rath, R. Redon, 2023, Science.

Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor

Jin-Hee Ahn, Kwonoh Park, Jae-Lyun Lee, 2014, Cancer research and treatment : official journal of Korean Cancer Association.

Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study

Hyo Song Kim, Tae Won Kim, Jin-Hee Ahn, 2020, Targeted Oncology.

Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma

Jin-Hee Ahn, Jeeyun Lee, S. Rha, 2012, Cancer Chemotherapy and Pharmacology.

Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab

H. Lee, G. Gong, K. Jung, 2021, Journal of breast cancer.

Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.

Sung-Bae Kim, Yeon-Hee Park, Y. Im, 2017, European journal of cancer.

Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets

H. Lee, S. Y. Park, G. Gong, 2014, Annals of Surgical Oncology.

Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer

Hyo Song Kim, Y. Bang, Jin-Hee Ahn, 2017, Oncotarget.

Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

Sung-Bae Kim, Yeon-Hee Park, Y. Im, 2019, Cancer communications.

Angiosarcoma of the Retroperitoneum: Report on a Patient Treated with Sunitinib

Song-Cheol Kim, Tae Won Kim, Jin-Hee Ahn, 2009, Sarcoma.

Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling

H. Lee, G. Gong, Jin-Hee Ahn, 2016, Oncotarget.

Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes

H. Lee, G. Gong, Jeong-ju Lee, 2015, Breast Cancer Research and Treatment.

A phase I study of TGF-β inhibitor, vactosertib in combination with imatinib in patients with advanced desmoid tumor (aggressive fibromatosis).

Jeeyun Lee, S. Hwang, Seong-Jin Kim, 2020 .

18F‐fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: A retrospective cohort study

Sung-Bae Kim, S. Ahn, G. Gong, 2013, Journal of surgical oncology.

Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus

In Seok Yang, Min Goo Lee, Hyo Song Kim, 2016, Oncotarget.

Successful Treatment with Ganciclovir for Cytomegalovirus Duodenitis following Allogenic Bone Marrow Transplantation

Hwoong-Yong Jung, Jin-Hee Ahn, Je-Hwan Lee, 1999, The Korean journal of internal medicine.

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients

Jin-Hee Ahn, Min-Woo Jo, H. Kim, 2012, Health and Quality of Life Outcomes.

Epidermal Growth Factor Receptor (EGFR) Expression in Operable Non-small Cell Lung Carcinoma

Seung‐Mo Hong, Sang-We Kim, Jin-Hee Ahn, 2004, Journal of Korean medical science.

Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors

Dae-Ho Lee, Jin-Hee Ahn, Y. Cho, 2016, Tumor Biology.

Concurrent Etoposide/Cisplatin Combination Chemotherapy (EP) and Thoracic Radiotherapy after Two Cycles of EP for Limited Stage Small Cell Lung Cancer.

Dong Sun Kim, Sarah Park, E. Choi, 2002, Cancer research and treatment : official journal of Korean Cancer Association.

The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma

E. Choi, Jin-Hee Ahn, Wanlim Kim, 2019, Radiation Oncology.

A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment

Jin-Hee Ahn, Je-Hwan Lee, Jung-shin Lee, 2001, British journal of haematology.

A phase 1 study of a heterologous prime-boost vaccination involving a truncated HER2 sequence in patients with HER2-expressing breast cancer

Sung-Bae Kim, K. Jung, Jin-Hee Ahn, 2015, Molecular therapy. Methods & clinical development.

Alternative Therapy and Abnormal Liver Function During Adjuvant Chemotherapy in Breast Cancer Patients

Sung-Bae Kim, Yoon-Koo Kang, Jin-Hee Ahn, 2004, Journal of Korean medical science.

Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea—A Sarcoma-Specific, Institutional Registry-Based Analysis

Kyung-Ja Cho, Jin-Hee Ahn, J. Song, 2021, Cancer management and research.

Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic Cancer

Tae Won Kim, H. Chang, Yoon-Koo Kang, 2002, Acta oncologica.

Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma.

Tae Won Kim, Dae-Ho Lee, Jin-Hee Ahn, 2009, Japanese journal of clinical oncology.

Characteristics of metastatic brachial plexopathy in patients with breast cancer

Sung-Bae Kim, K. Jung, S. Seo, 2019, Supportive Care in Cancer.

Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study

Sung-Bae Kim, H. Kim, K. Jung, 2013, Cancer Chemotherapy and Pharmacology.

Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer

H. Chang, Yoon-Koo Kang, Jin-Hee Ahn, 2002, Cancer Chemotherapy and Pharmacology.

Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR

Sang-We Kim, Dae-Ho Lee, Jin-Hee Ahn, 2015, BMC Cancer.

Efficacy and safety of docetaxel plus prednisolone chemotherapy for metastatic hormone-refractory prostate adenocarcinoma: single institutional study in Korea.

Dae-Ho Lee, Choung-Soo Kim, Jae-Lyun Lee, 2010, Cancer research and treatment : official journal of Korean Cancer Association.

Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab.

Jin-Hee Ahn, H. Lee, S. Y. Park, 2015, American journal of clinical pathology.

Randomized trial of postoperative adjuvant therapy in Stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: 10-year follow-up.

S. Ahn, C. Yu, Yoon-Koo Kang, 2011, International journal of radiation oncology, biology, physics.

TREATMENT OF L EG U LCERS W ITH P LATELET-DERIVED WOUND HEALING FACTOR (PDWHFS) I N A PATIENT W ITH B ETA THALASSAEMIA I NTERMEDIA

Jin-Hee Ahn, Je-Hwan Lee, Jung-shin Lee, 2001 .

CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience

Sung-Bae Kim, K. Jung, Jin-Hee Ahn, 2021, Journal of breast cancer.

21‐gene expression assay and clinical outcomes of premenopausal patients with hormone receptor‐positive breast cancer

Sung-Bae Kim, G. Gong, K. Jung, 2023, International journal of cancer.

Abstract A167: A phase I study of MET TKI SAR125844 in Asian patients (pts) with advanced solid tumors

Y. Bang, Tae Won Kim, D. Oh, 2015 .

Experience of Ovarian Function Suppression Therapy: Endocrine Response Preand Perimenopausal Korean Breast Cancer Patients in the Adjuvant Setting

Sung-Bae Kim, B. Son, Jin-Hee Ahn, 2007 .

Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor‐infiltrating lymphocytes (TILs) in breast cancer

H. Lee, G. Gong, Ahrong Kim, 2016, Pathology international.

Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer

Sung-Bae Kim, K. Jung, Jin-Hee Ahn, 2021, Cancer research and treatment.

High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers

Jin-Hee Ahn, H. Lee, G. Gong, 2015, Virchows Archiv.

Correlations Between Molecular Subtypes and Pathologic Response Patterns of Breast Cancers After Neoadjuvant Chemotherapy

H. Lee, G. Gong, Jeong-ju Lee, 2014, Annals of Surgical Oncology.

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer

V. Karantza, H. Iwata, H. Mukai, 2023, JAMA network open.

Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer

J. Ahn, G. Lyman, G. Curigliano, 2023, JAMA network open.

Clinical value of cyclooxygenase-2 expression in human breast carcinoma.

Sung-Bae Kim, S. Ahn, M. Ahn, 2004, Cancer research and treatment : official journal of Korean Cancer Association.

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer

Hee Jung Shin, Sung-Bae Kim, S. Ahn, 2021, Scientific Reports.

Role of Androgen Deprivation Treatment in Patients With Castration-Resistant Prostate Cancer, Receiving Docetaxel-Based Chemotherapy

Dae-Ho Lee, Choung-Soo Kim, Jin-Hee Ahn, 2010, American journal of clinical oncology.

Randomized phase II trial of sunitinib four-week on and two-week off versus two-week on and one-week off in metastatic clear cell type renal cell carcinoma: RESTORE trial.

Dae-Ho Lee, Jin-Hee Ahn, M. K. Kim, 2015 .

Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor

Dae-Ho Lee, Jin-Hee Ahn, Jae-Lyun Lee, 2015, Cancer Chemotherapy and Pharmacology.